logo
Send Message

Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2

5mg
MOQ
Please consult customer service
Price
Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2
Features Gallery Product Description Request A Quote
Features
Specifications
Color: White Powder
Brand Name: Kaihuida
Form: Powder
Highlight:

CAS 2023788-19-2 Tirzepatide

,

Lyophilized Peptides Tirzepatide

,

Weight Loss Tirzepatide

Basic Infomation
Place of Origin: China
Brand Name: KHD
Model Number: 2023788-19-2
Payment & Shipping Terms
Packaging Details: 1kg/bag,25kg/drum
Delivery Time: 2-5 days
Payment Terms: T/T, Western Union,Bitcoin
Supply Ability: 10000kg/Day
Product Description

Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide for Weight Loss CAS 2023788-19-2

Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2 0

Product name Tirzepatide
Appearance White powder
Purity 99%
Storage Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Life 24 Months

Description

Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment
of type 2 diabetes (T2D) and obesity.

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily
based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid
moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial
involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions
in the glycated hemoglobin level and weight at 26 weeks.

Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2
diabetes at doses up to 1 mg. In trials involving patients who received semaglutide, the mean reductions in the
glycated hemoglobin level have been reported to be as high as 1.8 percentage points and the mean reductions in
body weight have been reported to be as high as 6.5 kg.



Application&Function

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with
overweight and at least one weight-related condition, according to an agency press release.

This is a once-weekly injectable, which is more tolerable way of managing obesity vs. other treatments. The STEP
study data showed semaglutide 2.4 mg crosses the magic threshold of 10% weight loss for many people who received it.
This is another tool that will allow clinicians to better manage obesity.


1.Helps prevent your liver from making too much sugar

2.Helps the pancreas produce more insul when your blood sugar levels are high control blood glucose

3.Can reduce hyperglycemia, especially after meals Can reduce fasting insul and fasting glucose

4.Can reduce hemoglobin A1c,Can decrease appetite and caloric intake, while inhibiting weight gain

5.Has been shown to lower triglyceride levels and oxidative stress from high LDL

6.Has been shown to help induce weight loss in obese patients with higher dosing

 Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2 1

 

 

 

 

Contact:Mrs.Ella

Sales Manager

Jiangsu Kaihuida New Material Technology Co., Ltd

E-mail:ella@jskaihuida.com
 

 

Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2 2

 

Jiangsu Kaihuida New Material Technology Co., Ltd. is a scientific and technological company engaged in the development, production and operation of chemical products.

Our main products:Pharmaceutical intermediates,Food additive,Flavor,Organic intermediate,Cosmetic materials,Chemical Raw materials,Daily chemicals,Dye intermediate,Disinfectant,and other products.

Our main sales market:the United States,Canada,Mexico, Australia,the United Kingdom,France,Germany,Italy,South Korea, the Netherlands,Sweden,Spain,Switzerland,Colombia and other countries and regions.

 

Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2 3

 

Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2 4

 

 

 Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2 5

Obesity Treatment Lyophilized Peptides Tirzepatide Gip/GLP-1 Tirzepatide For Weight Loss CAS 2023788-19-2 6

 

Q1. Can I have a sample order for your products?
A: Yes, we welcome sample order to test and check quality. Mixed samples are acceptable.
Q2. What about the lead time?
A:Sample needs 3-5 days, mass production time needs 1-2 weeks for order quantity more than
Q3. Do you have any MOQ limit for order?
A: Low MOQ, 10-100g for sample checking is available
Q4. How do you ship the goods and how long does it take to arrive?
A: We usually ship by DHL, UPS, FedEx or TNT. It usually takes 3-5 days to arrive. Airline and sea shipping also optional.
Q5. How to proceed an order for your products?
A: Firstly let us know your requirements or application.
Secondly We quote according to your requirements or our suggestions.
Thirdly customer confirms the samples and places deposit for normal order.
Fourthly We arrange the production.
Q6. Is it OK to print my logo on package?
A: Yes. Please inform us before our production and confirm the design firstly based on our sample.
Q7: Are you trading company or manufacturer?
A: We are chemical factory in China. So we can provide wholesale price.

Recommended Products
Get in touch with us
Contact Person : Ella
Tel : +8618952196037
Characters Remaining(20/3000)